High-mobility group nucleosome-binding domain 2 protein inhibits the invasion of Klebsiella pneumoniae into mouse lungs in vivo

Mol Med Rep. 2015 Jul;12(1):1279-85. doi: 10.3892/mmr.2015.3464. Epub 2015 Mar 10.

Abstract

Since bacterial invasion into host cells is a critical step in the infection process and the predominance of multiple-antibiotic-resistant Klebsiella (K.) pneumoniae strains, using molecular agents to interfere with K. pneumoniae invasion is an attractive approach for the prevention of infection and suppress the immune inflammatory response. In previous studies by our group, high-mobility group nucleosome-binding domain 2 (HMGN2) protein was shown to exhibit anti-bacterial activity in vitro. The objective of the present study was to investigate the effects of HMGN2 protein on the invasion of K. pneumoniae 03183 in vivo. The results showed that pre-treatment with 128 µg/ml HMGN2 significantly reduced K. pneumoniae 03183 invasion into mouse lungs and increased the mRNA expression of CXCL1 and LCN2 within 2 h. Immunohistochemical staining showed that F-actin expression was significantly decreased, and fluorescence microscopy and western blot analysis further demonstrated that HMGN2 significantly blocked K. pneumoniae 03183-induced actin polymerization. These changes implied that HMGN2 may provide protection against K. pneumoniae 03183 infection in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Actins / immunology
  • Acute-Phase Proteins / agonists
  • Acute-Phase Proteins / genetics
  • Acute-Phase Proteins / immunology
  • Animals
  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / pharmacology*
  • Chemokine CXCL1 / agonists
  • Chemokine CXCL1 / genetics
  • Chemokine CXCL1 / immunology
  • Female
  • Gene Expression
  • HMGN2 Protein / biosynthesis
  • HMGN2 Protein / pharmacology*
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / immunology
  • Klebsiella Infections / microbiology
  • Klebsiella Infections / pathology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / physiology
  • Lipocalin-2
  • Lipocalins / agonists
  • Lipocalins / genetics
  • Lipocalins / immunology
  • Lung / drug effects*
  • Lung / microbiology
  • Mice
  • Mice, Inbred C57BL
  • Oncogene Proteins / agonists
  • Oncogene Proteins / genetics
  • Oncogene Proteins / immunology
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / immunology
  • Pneumonia, Bacterial / microbiology
  • Pneumonia, Bacterial / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / immunology
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / pharmacology

Substances

  • Actins
  • Acute-Phase Proteins
  • Anti-Bacterial Agents
  • Chemokine CXCL1
  • Cxcl1 protein, mouse
  • HMGN2 Protein
  • Lipocalin-2
  • Lipocalins
  • Oncogene Proteins
  • RNA, Messenger
  • Recombinant Proteins
  • Lcn2 protein, mouse